We are committed to redefining healthcare: connecting the best of Health&Care for every provider, for every patient, for everyone. Imagine all the amazing things those two simple words can do.
Innovative Medicine
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiopulmonary and Specialty ophthalmology.
MedTech
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.
Innovating in Health&Care
Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
Using your own cells to fight cancer
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.
The future of immunology
Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list
The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.
What is metastatic cancer?
The number of people living with this advanced form of cancer is on the rise. Learn how Johnson & Johnson is pioneering innovations to help patients live longer.
2025 Annual Meeting of Shareholders
April 24, 2025, 10 AM Eastern Time
Learn more about how we are innovating
Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis
They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.
A day in the life of a nurse innovator
For more than 125 years, Johnson & Johnson has championed nurses—providing resources and expanding opportunities for these frontline healthcare professionals. Follow along with one such trailblazer on a typical workday.
An eye for innovation: helping surgeons see more during spinal operations
With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
“My family and I volunteer on a floating hospital that delivers medical care”
Lee-Anne James is a Johnson & Johnson clinical research manager whose home base is Australia. That is, when she and her family aren’t donating their time to Mercy Ships to help treat people who lack access to lifesaving healthcare.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But a number of scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed what kind of prognosis many of these patients will have.
5 things we now know about myasthenia gravis
For Myasthenia Gravis Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.